Trading on the OTC market, Bioxytran, Inc. ($BIXT) opens its mission to a wide range of investors. With an open price of $0.175 and over 137.77 million outstanding shares, the company is positioned to raise awareness about the critical issue of hypoxia and its potential life-saving solutions.